"A case of Liddle syndrome (LS)" with great interest which drew attention to the distinction between LS and Apparent Mineralocorticoid Excess (AME) with response to spironolactone [1] . However, there are some reports regarding the dosage and ineffectiveness of spironolactone on this subject [2] [3] [4] [5] . I would like to share my experience to draw attention to the limitation of differential diagnosis with spironolactone on a hypertensive patient.
To the Editor: I read the article "A case of Liddle syndrome (LS)" with great interest which drew attention to the distinction between LS and Apparent Mineralocorticoid Excess (AME) with response to spironolactone [1] . However, there are some reports regarding the dosage and ineffectiveness of spironolactone on this subject [2] [3] [4] [5] . I would like to share my experience to draw attention to the limitation of differential diagnosis with spironolactone on a hypertensive patient.
A 4.5-y-old boy presented with hypertensive encephalopathy. Medical history revealed polyuria, failure to thrive, low birth weight, consanguineous parents, intrauterine death of the first sibling, and lack of family history of hypertension. Physical examination was normal except for the presence of lethargy and high blood pressure (BP) (185/135 mm Hg). Laboratory investigations revealed plasma sodium 146 mEq/L, potassium 1.6 mEq/L, chloride 97 mEq/L, bicarbonate 31.3 mEq/L, creatinine 0.6 mg/dl; urine sodium 45 mEq/L, potassium 15.2 mEq/L, chloride 52 mEq/L and creatinine 13 mg/dl. Supine plasma renin activity was 0.02 ng/ml/h (0.05-2.5) and the aldosterone level was 15 pg/ml (20-180). Nitroprusside continuous IV infusion was initiated and titrated according to the BP; then spironolactone was initiated and the dosage was increased up to 12 mg/kg/d. In spite of the continued nitroprusside infusion, BP could not be controlled. Combined triamterine (8 mg/kg) and hydrochlorothiazide [(4 mg/kg) (TH; only combined form is available in Turkey)] was prescribed while spironolactone was withdrawn. BP control was achieved on the 8th day. Parents' consanguinity and the lack of family history of hypertension urged me to test spironolactone for the diagnosis of AME again. On the 11th day of hospitalization 12 mg/kg/d spironolactone was reinstituted and TH was withdrawn. His BP rose up to 180/ 110 mm Hg and TH was prescribed again. Evaluation of ENaC α, β, γ and MR genes revealed no mutation. Recently, the urinary steroid metabolomics analysis revealed pathologic ratio of tetrahydrocortisol +5α-tetrahydrocortisol/ tetrahydrocortisone (7.39; normal: < 2.5) and definitive diagnosis was established as AME. He is now on TH and spironolactone. Thus, spironolactone test is not a safe and sensitive method for differential diagnosis of AME and LS.
